Characteristics and treatment of rheumatologic adverse events associated with immune checkpoint inhibitors: A multicentric prospective cohort study.

Amine Mouamnia,Renaud Desbarbieux,Laurent Mortier,Arnaud Scherpereel,Sylvain Dubucquoi,René-Marc Flipo,Peggy Philippe,Bernard Cortet,Marie-Hélène Vieillard

Characteristics and treatment of rheumatologic adverse events associated with immune checkpoint inhibitors: A multicentric prospective cohort study.

2019

Amine Mouamnia
Renaud Desbarbieux
Laurent Mortier
Arnaud Scherpereel
Sylvain Dubucquoi
René-Marc Flipo
Peggy Philippe
Bernard Cortet
Marie-Hélène Vieillard

e14133Background: To characterise the specific rheumatologic immune-related adverse events (irAEs) in patients with cancer treated by immune checkpoint inhibitors (ICI), and to propose a treatment ...

Keywords:

Prospective cohort study
Physical therapy
Immune checkpoint
Oncology
Adverse effect
Internal medicine
Medicine
in patient
Cancer
Pathology
immune checkpoint inhibitors

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations